Dose adjustment in renal impairment: Response from AHFS Drug Information

BMJ

Volumn 331, Issue 7511, 2005, Pages 293-

  Mcevoy, Gerald K ^a  

^a AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BOOK; HUMAN; KIDNEY DISEASE; NOTE; STANDARD; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; KIDNEY DISEASES; PHARMACEUTICAL PREPARATIONS; REFERENCE BOOKS;

EID: 23244441614     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.331.7511.293     Document Type: Article

References (5)

1. McEvoy GK, ed. AHFS drug information 2005. Bethesda, MD: American Society of Health-System Pharmacists, 2005.
2. McEvoy GK. Drug information resources and medication safety. In: Manasse HR Jr, Thompson KK, eds. Medication safety: a guide for health care facilities. Bethesda, MD: American Society of Health-System Pharmacists; 2005: 253 274.
3. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 2005; 331: 263–6 (30 July.)
4. US Food and Drug Administration Centers for Drug Evaluation and Research (CDER) and for Biologics Evaluation and Research (CBER). Guidance for industry: pharmacokinetics in patients with impaired renal function–study design, data analysis, and impact on dosing and labeling. Rockville, MD: US Department of Health and Human Services, 1998. Available at
5. McEvoy GK. Obtaining references for AHFS drug information monographs. Am J Hosp Pharm 1987; 44: 1552.